Tourette syndrome Archives

Swiss Startup Hits the Ground Running for Rare Neurological Diseases

Business, Clinical Trials, Financing, Licensing, Neurological Diseases, Orphan CNS Disorders, Pain Conditions, R&D, Series A, Start-ups, Switzerland, Tourette syndrome, Trigeminal neuralgia, Tuberous Sclerosis Complex (TSC)

Switzerland-based Noema Pharma raised $59 million in a Series A financing round that will support the development of four clinical-stage assets the company licensed from Roche for the treatment of orphan neurological diseases with severe unmet needs.

December 1, 2020/by BioSpace

Lundbeck to acquire Abide Therapeutics

Acquisitions, Business, Central Nervous System Diseases, Enzymes, Serine hydrolase inhibitors, Tourette syndrome

The acquisition of Abide Therapeutics Inc. will provide H. Lundbeck A/S with a unique discovery platform and a lead compound in an exploratory phase IIa program for Tourette’s syndrome.

May 6, 2019/by GlobeNewswire